Suspension of Nasdaq Minimum Bid Price Buys Nanogen More Time for Compliance

Oct 28, 2008

NEW YORK (GenomeWeb News) – Due to a recent suspension by Nasdaq of certain listing requirements, Nanogen now has until Feb. 26, 2009, to gain compliance with the exchange’s $1 minimum bid rule, the firm said in a filing with the US Securities and Exchange Commission yesterday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu